NCT06792344View on ClinicalTrials.gov

Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Systemic Sclerosis (SSc)
Interventions
OTHER

anti-CD19 CAR-T cells

Intravenous injection the targeting CD19 CAR T cell

DRUG

anti-CD19 CAR-T cells

CD19-targeting CAR-T cells

Trial Locations (2)

310053

RECRUITING

Children's Hospital, Zhejiang University School of Medicine, Hangzhou

0571

RECRUITING

Children's Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

The Children's Hospital of Zhejiang University School of Medicine

OTHER